Efficacy of cabozantinib and sunitinib for the treatment of intermediate/poor risk renal cell carcinoma based upon UK real-world data
| Autor: | Lee, D., Melendez-Torres, G.J., Challapalli, A., Frazer, R., McGrane, J., Bahl, A. |
|---|---|
| Zdroj: | In ESMO Real World Data and Digital Oncology December 2024 6 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|